Shengming Jin

712 total citations
32 papers, 481 citations indexed

About

Shengming Jin is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Shengming Jin has authored 32 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 14 papers in Surgery and 13 papers in Molecular Biology. Recurrent topics in Shengming Jin's work include Bladder and Urothelial Cancer Treatments (11 papers), Ferroptosis and cancer prognosis (6 papers) and Circular RNAs in diseases (6 papers). Shengming Jin is often cited by papers focused on Bladder and Urothelial Cancer Treatments (11 papers), Ferroptosis and cancer prognosis (6 papers) and Circular RNAs in diseases (6 papers). Shengming Jin collaborates with scholars based in China, United States and Austria. Shengming Jin's co-authors include Chen Yang, Siqi Wu, Haowen Jiang, Xinan Chen, Dingwei Ye, Junlong Wu, Zezhong Mou, Quan Zhou, Yuxi Ou and Limin Zhang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Shengming Jin

29 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengming Jin China 13 290 210 165 84 74 32 481
Janet Taylor United Kingdom 7 259 0.9× 304 1.4× 125 0.8× 88 1.0× 100 1.4× 10 505
Zongtai Zheng China 13 233 0.8× 164 0.8× 176 1.1× 128 1.5× 97 1.3× 37 504
Zetian Shen China 13 214 0.7× 174 0.8× 126 0.8× 70 0.8× 109 1.5× 30 439
Zhicheng He China 11 430 1.5× 347 1.7× 176 1.1× 57 0.7× 64 0.9× 34 647
Xujie Gao China 11 294 1.0× 280 1.3× 136 0.8× 53 0.6× 75 1.0× 16 487
Caipeng Qin China 12 202 0.7× 95 0.5× 93 0.6× 49 0.6× 85 1.1× 41 359
Julien Dagher France 12 216 0.7× 125 0.6× 375 2.3× 65 0.8× 179 2.4× 23 509
He-San Luo China 12 194 0.7× 115 0.5× 151 0.9× 162 1.9× 158 2.1× 24 450
Runhua Feng China 11 302 1.0× 321 1.5× 106 0.6× 84 1.0× 95 1.3× 25 515
Sumi Yun South Korea 12 190 0.7× 150 0.7× 119 0.7× 64 0.8× 215 2.9× 25 469

Countries citing papers authored by Shengming Jin

Since Specialization
Citations

This map shows the geographic impact of Shengming Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengming Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengming Jin more than expected).

Fields of papers citing papers by Shengming Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengming Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengming Jin. The network helps show where Shengming Jin may publish in the future.

Co-authorship network of co-authors of Shengming Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Shengming Jin. A scholar is included among the top collaborators of Shengming Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengming Jin. Shengming Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Tingting, Tao Feng, Wei Zhang, et al.. (2025). Neutrophil extracellular traps–STC1 positive feedback loop promotes immune evasion and metastasis in bladder cancer. Journal for ImmunoTherapy of Cancer. 13(11). e012736–e012736.
2.
Jin, Shengming, et al.. (2025). Comprehensive analysis of the LINC01122/TPD52 axis as a predictive biomarker in prostate adenocarcinoma. Scientific Reports. 15(1). 16122–16122.
3.
Pan, Jian, Junlong Wu, Bin Zhu, et al.. (2024). Interlesional response heterogeneity is associated with the prognosis of abiraterone treatment in metastatic castration-resistant prostate cancer. Med. 5(12). 1475–1484.e3. 5 indexed citations
5.
Yu, Wei, Jian Pan, Shengming Jin, et al.. (2023). Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity. Molecular Oncology. 17(10). 2183–2199. 6 indexed citations
6.
Chen, Siyuan, et al.. (2023). FGFR3 mutation characterization identifies prognostic and immune-related gene signatures in bladder cancer. Computers in Biology and Medicine. 162. 106976–106976. 5 indexed citations
7.
Jin, Shengming, Han Zeng, Zhaopei Liu, et al.. (2022). Stromal Tumor-Associated Macrophage Infiltration Predicts Poor Clinical Outcomes in Muscle-Invasive Bladder Cancer Patients. Annals of Surgical Oncology. 29(4). 2495–2503. 4 indexed citations
8.
Yu, Wei, Hao Zeng, Yonghong Li, et al.. (2022). Prevalence of mismatch repair genes mutations and clinical activity of PD-1 therapy in Chinese prostate cancer patients. Cancer Immunology Immunotherapy. 72(6). 1541–1551. 11 indexed citations
9.
Yang, Chen, Siqi Wu, Zezhong Mou, et al.. (2022). Exosome-derived circTRPS1 promotes malignant phenotype and CD8+ T cell exhaustion in bladder cancer microenvironments. Molecular Therapy. 30(3). 1054–1070. 127 indexed citations
10.
Shang, Zhi, Shengming Jin, Wenwen Wang, et al.. (2022). Clinicopathological characteristics and loss of mismatch repair protein expression in Chinese upper tract urothelial carcinomas. Frontiers in Oncology. 12. 1012168–1012168. 3 indexed citations
11.
Zhang, Jianping, Shengming Jin, Wenjun Xiao, et al.. (2021). Long noncoding RNA LINC00641 promotes renal cell carcinoma progression via sponging microRNA-340-5p. Cancer Cell International. 21(1). 210–210. 12 indexed citations
12.
Jin, Shengming, Wei Yu, Junlong Wu, et al.. (2021). The genomic landscape of Chinese patients with upper tract urothelial carcinoma.. Journal of Clinical Oncology. 39(15_suppl). e16583–e16583. 1 indexed citations
13.
Wang, Wei, Kaiming Cao, Shengming Jin, et al.. (2020). Differentiation of renal cell carcinoma subtypes through MRI-based radiomics analysis. European Radiology. 30(10). 5738–5747. 48 indexed citations
14.
Wang, Jun, Mierxiati Abudurexiti, Shengming Jin, et al.. (2020). Prognosis of Patients With Testicular Carcinoma Is Dependent on Metastatic Site. Frontiers in Oncology. 9. 1495–1495. 15 indexed citations
15.
Jin, Shengming, Junjie Wang, Junlong Wu, et al.. (2020). Prognostic Value of Local Treatment in Prostate Cancer Patients With Different Metastatic Sites: A Population Based Retrospective Study. Frontiers in Oncology. 10. 527952–527952. 4 indexed citations
16.
Chen, Qi, Zheyu Zhang, Siqi Wu, et al.. (2020). Hsa_circ_0068307 mediates bladder cancer stem cell-like properties via miR-147/c-Myc axis regulation. Cancer Cell International. 20(1). 151–151. 24 indexed citations
17.
Jin, Shengming, Yiping Zhu, Weixing Dai, et al.. (2019). Log Odds Could Better Predict Survival in Muscle-Invasive Bladder Cancer Patients Compared with pN and Lymph Node Ratio. Journal of Cancer. 10(1). 249–256. 16 indexed citations
18.
Wu, Junlong, Shengming Jin, Weijie Gu, et al.. (2019). Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma. Frontiers in Oncology. 9. 152–152. 22 indexed citations
19.
Jin, Shengming, Junjie Wang, Yijun Shen, et al.. (2019). Comparison of different lymph node staging schemes in prostate cancer patients with lymph node metastasis. International Urology and Nephrology. 52(1). 87–95. 6 indexed citations
20.
Jin, Shengming, Junlong Wu, Yao Zhu, et al.. (2018). Comprehensive Analysis of BAP1 Somatic Mutation in Clear Cell Renal Cell Carcinoma to Explore Potential Mechanisms in Silico. Journal of Cancer. 9(22). 4108–4116. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026